These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 31513868

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Co-Delivery of D-LAK Antimicrobial Peptide and Capreomycin as Inhaled Powder Formulation to Combat Drug-Resistant Tuberculosis.
    Shao Z, Chow MYT, Chow SF, Lam JKW.
    Pharm Res; 2023 May; 40(5):1073-1086. PubMed ID: 36869245
    [Abstract] [Full Text] [Related]

  • 23. Colistin powders with high aerosolisation efficiency for respiratory infection: preparation and in vitro evaluation.
    Zhou QT, Morton DA, Yu HH, Jacob J, Wang J, Li J, Chan HK.
    J Pharm Sci; 2013 Oct; 102(10):3736-47. PubMed ID: 23904207
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Active pulmonary targeting against tuberculosis (TB) via triple-encapsulation of Q203, bedaquiline and superparamagnetic iron oxides (SPIOs) in nanoparticle aggregates.
    Poh W, Ab Rahman N, Ostrovski Y, Sznitman J, Pethe K, Loo SCJ.
    Drug Deliv; 2019 Dec; 26(1):1039-1048. PubMed ID: 31691600
    [Abstract] [Full Text] [Related]

  • 26. Synergistic combination of antimicrobial peptide and isoniazid as inhalable dry powder formulation against multi-drug resistant tuberculosis.
    Shao Z, Tam KK, Achalla VPK, Woon ECY, Mason AJ, Chow SF, Yam WC, Lam JKW.
    Int J Pharm; 2024 Apr 10; 654():123960. PubMed ID: 38447778
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Porous particles and novel carrier particles with enhanced penetration for efficient pulmonary delivery of antitubercular drugs.
    Tse JY, Koike A, Kadota K, Uchiyama H, Fujimori K, Tozuka Y.
    Eur J Pharm Biopharm; 2021 Oct 10; 167():116-126. PubMed ID: 34363979
    [Abstract] [Full Text] [Related]

  • 29. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial.
    Diacon AH, Dawson R, von Groote-Bidlingmaier F, Symons G, Venter A, Donald PR, van Niekerk C, Everitt D, Winter H, Becker P, Mendel CM, Spigelman MK.
    Lancet; 2012 Sep 15; 380(9846):986-93. PubMed ID: 22828481
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Pharmaceutical formulation of a fixed-dose anti-tuberculosis combination.
    Danckwerts MP, Ebrahim S, Pillay V.
    Int J Tuberc Lung Dis; 2003 Mar 15; 7(3):289-97. PubMed ID: 12661846
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Improved Aerosolization Stability of Inhalable Tobramycin Powder Formulation by Co-Spray Drying with Colistin.
    Pathak V, Park H, Zemlyanov D, Bhujbal SV, Ahmed MU, Azad MAK, Li J, Zhou QT.
    Pharm Res; 2022 Nov 15; 39(11):2781-2799. PubMed ID: 35915320
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. In vitro interaction profiles of the new antitubercular drugs bedaquiline and delamanid with moxifloxacin against clinical Mycobacterium tuberculosis isolates.
    Chandramohan Y, Padmanaban V, Bethunaickan R, Tripathy S, Swaminathan S, Ranganathan UD.
    J Glob Antimicrob Resist; 2019 Dec 15; 19():348-353. PubMed ID: 31226332
    [Abstract] [Full Text] [Related]

  • 40. Dry powder inhalers of gentamicin and leucine: formulation parameters, aerosol performance and in vitro toxicity on CuFi1 cells.
    Aquino RP, Prota L, Auriemma G, Santoro A, Mencherini T, Colombo G, Russo P.
    Int J Pharm; 2012 Apr 15; 426(1-2):100-107. PubMed ID: 22301426
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.